Lexiscan (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardiology 2010 - Drugs.com MedNews
Links shared publicly online about this topic.
- 843total visits
Lexiscan (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardiology 2010 - Drugs.com MedNews
View full resource at drugs.com
Tags: Asthma, COPD, COPD Medication, Disease and Condition, Drug, Pulmonology, disease
Most Recently Shared on September 27, 2010 at 3:15 pm By:
Lexiscan (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD... http://bit.ly/bl8lmi #drug
Lexiscan (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD)... -- PHILADELPHIA, Sept. 25 /PRNewswire/ --
prnewswire.com — “Lexiscan (Regadenoson) Injection Study in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD) Presented as Late-Breaker at American Society of Nuclear Cardiology 2010. -Phase IV Data Meets Primary Endpoint-.” View full resource at prnewswire.com
Most Recently Shared on September 25, 2010 at 11:07 am By:
Michael Blaiss, MD Doctor, Allergist, and Physician
Lexiscan® (Regadenoson) Injection Study in Subjects With Asthma or COPD... -- PHILADELPHIA, Sept. 25 /PRNewswire/ -- http://is.gd/fsqup
Advertisement
